Tivic Harnessing the immune system to improve outcomes and save lives. Recent Developments Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod Tivic Growth Backed By $90M+ Financing Package View Press Release Our Areas of Focus Latest Press Releases View All